Artia Global Partners LP Astrazeneca PLC Transaction History
Artia Global Partners LP
- $395 Billion
- Q1 2025
A detailed history of Artia Global Partners LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Artia Global Partners LP holds 190,752 shares of AZN stock, worth $13.3 Million. This represents 3.55% of its overall portfolio holdings.
Number of Shares
190,752
Previous 190,752
-0.0%
Holding current value
$13.3 Million
Previous $12.5 Billion
12.18%
% of portfolio
3.55%
Previous 4.47%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.98 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.83 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.48 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.22 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.18 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $216B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...